Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Therion's Prostvac vaccine shows promise in phase I prostate cancer study

May 15, 2000

Important drug warning issued for Herceptin

May 12, 2000

Patients with ovarian cancer sought for phase III trial

May 11, 2000

Multikine shows promising efficacy and safety in phase II trial

May 11, 2000

FDA grants fast track status to Biomira's breast cancer vaccine

May 10, 2000

Maxamine plus IL-2 improves survival in late-stage malignant melanoma

May 4, 2000

Neurocrine Biosciences obtains orphan drug status for glioblastoma therapy

May 2, 2000

Neurocrine Biosciences reports positive results from phase I/II malignant glioma trial

April 27, 2000

Campath MAA accepted for review by European authorities

April 26, 2000

Novelos Therapeutics initiates first U.S. trial of BAM-002

April 25, 2000

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...